Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
" "
FOOD AND DRUG ADMINISTRATION
FOR IMMEDIATE RELEASE
Consumer Media: 888-Info-FDA
July 20, 1999

UDL Laboratories, Inc. Recalls Trihexyphenidyl Hydrochloride Tablets

Rockford, IL (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that UDL Laboratories, Inc. is recalling Trihexyphenidyl Hydrochloride Tablets because of mislabeling.  Some blister strips are held in shelf unit cartons (100's) labeled as Allopurinol Tablets, 300 mg. The blister strips are correctly labeled.

PRODUCT
Trihexyphenidyl Hydrochloride Tablets, 5 mg, in 100 tablet blister strips of 10 tablets, Rx oral antispasmodic tablet used as an adjunct in the treatment of all forms of parkinsonism. NDC 51079-124-20.

Recall #D-278-9.

CODE
Lot #8V938.

MANUFACTURER
Lederle Pharmaceutical, Division of American Cyanamid, Pearl River, New York.

RECALLED BY
UDL Laboratories, Inc., Rockford, Illinois (repacker), by letter dated June 14, 1999. Firm-initiated recall ongoing.

DISTRIBUTION
Nationwide.

QUANTITY
3,624 unit cartons were distributed; firm estimated that 25 percent of the product remained on market at time of recall initiation.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.